Skip Navigation
Skip to contents

JYMS : Journal of Yeungnam Medical Science

Indexed in: ESCI, Scopus, PubMed,
PubMed Central, CAS, DOAJ, KCI
FREE article processing charge
OPEN ACCESS
SEARCH
Search
Advanced Search
mobile menu button

Search

Page Path
HOME > Search
1 "Severe asthma"
Filter
Filter
Article category
Keywords
Publication year
Authors
Focused Review article
Pulmonary and Respiratory Medicine
Biological treatments for severe asthma
Hyun Jung Jin
Yeungnam Univ J Med. 2020;37(4):262-268.   Published online September 11, 2020
DOI: https://doi.org/10.12701/yujm.2020.00647
  • 10,810 View
  • 195 Download
  • 14 Crossref
AbstractAbstract PDF
Severe asthma patients comprise about 3% to 13% of all asthma patients, but they have higher hospital utilization rates and higher medical costs than those of nonsevere asthma patients. Treatment methods for severe asthma patients are still lacking; however, the recent development of biologics is expected to have a positive effect. The biological therapies developed so far are mainly aimed at treating asthma patients with type 2 inflammation. These biologics have been found to reduce symptoms of asthma, improve lung function, reduce the use of oral corticosteroids, and improve quality of life of patients. This article reviews the mechanism of action and indications for approved biologics and discusses what should be considered when choosing biologics.

Citations

Citations to this article as recorded by  
  • Advanced bispecific antibody design and inhaled biologics; emerging strategies for asthma
    Zeina Kassem, Jenny K. W. Lam, Hanieh Khalili
    RSC Pharmaceutics.2026;[Epub]     CrossRef
  • Allergen Immunotherapy for the Prevention and Treatment of Asthma
    Thierry Batard, Camille Taillé, Laurent Guilleminault, Andrzej Bozek, Véronique Bordas‐Le Floch, Oliver Pfaar, Walter G. Canonica, Cezmi Akdis, Mohamed H. Shamji, Laurent Mascarell
    Clinical & Experimental Allergy.2025; 55(2): 111.     CrossRef
  • Determinants of cost-effectiveness results of biological therapies for severe asthma: a systematic methodological assessment
    Laura de la Torre-Pérez, Marilina Santero, Wendy Nieto-Gutierrez, Christine Giesen, Angela Nardin, Claudia Cosma, Pedro Silva Pires, Andrea Guida, Marcello Simonini, Camila Quirland Lazo, Feng Xie, Pablo Alonso-Coello
    Journal of Clinical Epidemiology.2025; 178: 111621.     CrossRef
  • Current and Novel Biologic Therapies for Patients with Asthma and Nasal Polyps
    Hanna K. Mandl, Jessa E. Miller, Daniel M. Beswick
    Otolaryngologic Clinics of North America.2024; 57(2): 225.     CrossRef
  • Moderate-High Blood Eosinophilia Is Associated with Increased Hospitalization and Other Asthma Comorbidities
    Sara Naharro-González, Clara Lorente-Sorolla, José Manuel Rodrigo-Muñoz, Marcela Valverde-Monge, Erwin Javier Pinillos-Robles, Diana Betancor, Mar Fernández-Nieto, Diana Sánchez-Mellado, Marta Gil-Martínez, Jessica Mireya Santillán-Coello, José Miguel Vil
    Biomolecules.2024; 14(1): 126.     CrossRef
  • Biologic Therapies across Nasal Polyp Subtypes
    Kody G. Bolk, Sarah K. Wise
    Journal of Personalized Medicine.2024; 14(4): 432.     CrossRef
  • Evaluation of multiple-flows exhaled nitric oxide and its clinical significance in severe asthmatic patients treated with biologics: a prospective real-life study
    Tommaso Pianigiani, Simona Luzzi, Akter Dilroba, Martina Meocci, Elisa Salvadori, Lorenzo Alderighi, Laura Bergantini, Miriana d’Alessandro, Piersante Sestini, Elena Bargagli, Paolo Cameli
    Journal of Asthma.2024; 61(12): 1619.     CrossRef
  • Long-term Safety and Efficacy of Dupilumab in Patients With Uncontrolled, Moderate-to-Severe Asthma Recruited From Korean Centers: A Subgroup Analysis of the Phase 3 LIBERTY ASTHMA TRAVERSE Trial
    Chin Kook Rhee, Jung-Won Park, Heung-Woo Park, Hayeon Noh, Jerome Msihid, You Sook Cho
    Allergy, Asthma & Immunology Research.2024; 16(4): 372.     CrossRef
  • Incremental net monetary benefit of biologic therapies in moderate to severe asthma: a systematic review and meta-analysis of economic evaluation studies
    Sajesh K. Veettil, Vanessa Vincent, Taylor Shufelt, Emma Behan, M. Sakil Syeed, Ammarin Thakkinstian, David C. Young, Nathorn Chaiyakunapruk
    Journal of Asthma.2023; 60(9): 1702.     CrossRef
  • Tackling the cytokine storm using advanced drug delivery in allergic airway disease
    Vyoma K. Patel, Sukriti Vishwas, Rajan Kumar, Gabriele De Rubis, Shakti D. Shukla, Keshav Raj Paudel, Bikash Manandhar, Thakur Gurjeet Singh, Dinesh Kumar Chellappan, Monica Gulati, Indu Pal Kaur, Venkata Sita Rama Raju Allam, Philip M. Hansbro, Brian G.
    Journal of Drug Delivery Science and Technology.2023; 82: 104366.     CrossRef
  • The evolving landscape of immunotherapy for the treatment of allergic conditions
    Aarti Pandya, Esosa Adah, Bridgette Jones, Rachel Chevalier
    Clinical and Translational Science.2023; 16(8): 1294.     CrossRef
  • Effect of Dupilumab in Korean Patients With Uncontrolled Moderate-to-Severe Asthma: A LIBERTY ASTHMA QUEST Sub-analysis
    Chin Kook Rhee, Jung-Won Park, Heung-Woo Park, You Sook Cho
    Allergy, Asthma & Immunology Research.2022; 14(2): 182.     CrossRef
  • The role of peripheral eosinophilia in diagnosing lung disorders: experience from a single pneumonological center
    Justyna Fijołek, Elzbieta Wiatr, Dorota Piotrowska-Kownacka, Kazimierz Roszkowski-Sliz
    Multidisciplinary Respiratory Medicine.2021;[Epub]     CrossRef
  • Advances in the science and treatment of respiratory diseases
    Jin Hong Chung
    Yeungnam University Journal of Medicine.2020; 37(4): 251.     CrossRef
JYMS : Journal of Yeungnam Medical Science
© Yeungnam University College of Medicine, Yeungnam University Institute of Medical Science.
TOP